Cytochrome P450 genotyping and antidepressants

British Medical Journal

Volumn 334, Issue 7597, 2007, Pages 759-

  Perlis, Roy H ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; CYTOCHROME P450; CYTOCHROME P450 2C19; CYTOCHROME P450 2D6; CYTOCHROME P450 3A; MONOAMINE OXIDASE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

CLINICAL PRACTICE; CLINICAL TRIAL; DEPRESSION; DRUG EFFICACY; DRUG METABOLISM; DRUG MONITORING; DRUG RESPONSE; DRUG TOLERABILITY; DRUG WITHDRAWAL; EDITORIAL; GENOTYPE; HUMAN; INSOMNIA; NAUSEA; PHARMACOGENETICS; PRESCRIPTION; PRIORITY JOURNAL; SEXUAL DYSFUNCTION; SIDE EFFECT; UNSPECIFIED SIDE EFFECT; WEIGHT GAIN;

ANTIDEPRESSIVE AGENTS; CYTOCHROME P-450 ENZYME SYSTEM; DEPRESSIVE DISORDER; GENOTYPE; HUMANS;

EID: 34247527031     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.39169.547512.80     Document Type: Editorial

References (0)